Daniel G. Marquess

1.3k total citations
28 papers, 922 citations indexed

About

Daniel G. Marquess is a scholar working on Molecular Biology, Organic Chemistry and Gastroenterology. According to data from OpenAlex, Daniel G. Marquess has authored 28 papers receiving a total of 922 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 17 papers in Organic Chemistry and 7 papers in Gastroenterology. Recurrent topics in Daniel G. Marquess's work include Chemical Synthesis and Analysis (10 papers), Carbohydrate Chemistry and Synthesis (7 papers) and Gastrointestinal motility and disorders (6 papers). Daniel G. Marquess is often cited by papers focused on Chemical Synthesis and Analysis (10 papers), Carbohydrate Chemistry and Synthesis (7 papers) and Gastrointestinal motility and disorders (6 papers). Daniel G. Marquess collaborates with scholars based in United States, United Kingdom and Australia. Daniel G. Marquess's co-authors include Daniel D. Long, Timothy D. W. Claridge, George W. J. Fleet, Jacqueline A.M. Smith, Martin D. Smith, David T. Beattie, P.P.A. Humphrey, R. Vickery, Scott R. Armstrong and Natasha L. Hungerford and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Communications and Journal of Medicinal Chemistry.

In The Last Decade

Daniel G. Marquess

28 papers receiving 886 citations

Peers

Daniel G. Marquess
Daniel L. Rathbone United Kingdom
William E. Perkins United States
Robert G. Bianchi United States
Tim Quach Australia
Tae‐Sung Koo South Korea
Sudershan K. Sanduja United States
Daniel G. Marquess
Citations per year, relative to Daniel G. Marquess Daniel G. Marquess (= 1×) peers Stefania Gagliardi

Countries citing papers authored by Daniel G. Marquess

Since Specialization
Citations

This map shows the geographic impact of Daniel G. Marquess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel G. Marquess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel G. Marquess more than expected).

Fields of papers citing papers by Daniel G. Marquess

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel G. Marquess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel G. Marquess. The network helps show where Daniel G. Marquess may publish in the future.

Co-authorship network of co-authors of Daniel G. Marquess

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel G. Marquess. A scholar is included among the top collaborators of Daniel G. Marquess based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel G. Marquess. Daniel G. Marquess is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Choi, Seok Ki, Joe Budman, Craig Hill, et al.. (2018). Discovery of TD-0212, an Orally Active Dual Pharmacology AT1 Antagonist and Neprilysin Inhibitor (ARNI). ACS Medicinal Chemistry Letters. 10(1). 86–91. 11 indexed citations
2.
Armstrong, Scott R., David T. Beattie, Daniel D. Long, et al.. (2013). Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties. Bioorganic & Medicinal Chemistry Letters. 23(14). 4210–4215. 12 indexed citations
3.
Long, Daniel D., Scott R. Armstrong, David T. Beattie, et al.. (2012). Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT4 receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipation. Bioorganic & Medicinal Chemistry Letters. 22(19). 6048–6052. 16 indexed citations
4.
Long, Daniel D., Scott R. Armstrong, David T. Beattie, et al.. (2012). Discovery, oral pharmacokinetics and in vivo efficacy of a highly selective 5-HT4 receptor agonist: Clinical compound TD-2749. Bioorganic & Medicinal Chemistry Letters. 22(14). 4849–4853. 8 indexed citations
5.
Long, Daniel D., Bryan A. Frieman, Sharath S. Hegde, et al.. (2012). A multivalent approach towards linked dual-pharmacology prostaglandin F receptor agonist/carbonic anhydrase-II inhibitors for the treatment of glaucoma. Bioorganic & Medicinal Chemistry Letters. 23(4). 939–943. 15 indexed citations
6.
Armstrong, Scott R., David T. Beattie, Seok Ki Choi, et al.. (2009). A Multivalent Approach to the Design and Discovery of Orally Efficacious 5-HT4Receptor Agonists. Journal of Medicinal Chemistry. 52(17). 5330–5343. 16 indexed citations
7.
Beattie, David T., Scott R. Armstrong, J P Shaw, et al.. (2008). The in vivo gastrointestinal activity of TD-5108, a selective 5-HT4 receptor agonist with high intrinsic activity. Naunyn-Schmiedeberg s Archives of Pharmacology. 378(1). 139–147. 43 indexed citations
8.
Long, Daniel D., James B. Aggen, Jason Chinn, et al.. (2008). Exploring the Positional Attachment of Glycopeptide/β-lactam Heterodimers. The Journal of Antibiotics. 61(10). 603–614. 36 indexed citations
9.
Beattie, David T., Jacqueline A.M. Smith, Daniel G. Marquess, et al.. (2004). The 5‐HT4 receptor agonist, tegaserod, is a potent 5‐HT2B receptor antagonist in vitro and in vivo. British Journal of Pharmacology. 143(5). 549–560. 104 indexed citations
12.
Claridge, Timothy D. W., Daniel D. Long, Natasha L. Hungerford, et al.. (1999). An octameric carbopeptoid; secondary structure in octameric and tetrameric 5-aminomethyl-tetrahydrofuran-2-carboxylates. Tetrahedron Letters. 40(11). 2199–2202. 63 indexed citations
13.
Long, Daniel D., Natasha L. Hungerford, Martin D. Smith, et al.. (1999). From sequencamers to foldamers? Tetrameric furanose carbopeptoids from cis- and trans-5-aminomethyl-tetrahydrofuran-2-carboxylates. Tetrahedron Letters. 40(11). 2195–2198. 52 indexed citations
14.
Long, Daniel D., Robert J. Nash, Daniel G. Marquess, et al.. (1999). Open-chain acetonides of D-galactono-1,4-lactone as starting materials for pyrrolidines, azepanes and 5-azidomethyltetrahydrofuran-2-carboxylates: monomers for polyhydroxylated nylon and for tetrahydrofuran carbopeptoids. Journal of the Chemical Society Perkin Transactions 1. 901–908. 25 indexed citations
15.
Smith, Martin D., Daniel D. Long, Timothy D. W. Claridge, George W. J. Fleet, & Daniel G. Marquess. (1998). Synthesis of oligomers of tetrahydrofuran amino acids: furanose carbopeptoids. Chemical Communications. 2039–2040. 39 indexed citations
16.
Long, Daniel D., Martin D. Smith, Daniel G. Marquess, Timothy D. W. Claridge, & George W. J. Fleet. (1998). A solid phase approach to oligomers of carbohydrate amino-acids: Secondary structure in a trimeric furanose carbopeptoid. Tetrahedron Letters. 39(50). 9293–9296. 31 indexed citations
17.
Armour, Duncan, Miles Congreve, A.B. Hawcock, et al.. (1997). 1,4-Benzodiazepin-2-one derived neurokinin-1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 7(15). 2037–2042. 9 indexed citations
18.
Baldwin, Jack E., Robert M. Adlington, Daniel G. Marquess, et al.. (1996). Evidence for an insertion-homolysis mechanism for carbon-sulphur bond formation in penicillin biosynthesis; 1. Synthesis of tripeptide probes. Tetrahedron. 52(7). 2515–2536. 15 indexed citations
19.
Baldwin, Jack E., Robert M. Adlington, Daniel G. Marquess, et al.. (1996). Evidence for an insertion-homolysis mechanism for carbon-sulphur bond formation in penicillin biosynthesis; 2. Incubation and interpretation. Tetrahedron. 52(7). 2537–2556. 9 indexed citations
20.
Baldwin, Jack E., Robert M. Adlington, Daniel G. Marquess, Andrew R. Pitt, & Andrew T. Russell. (1991). Evidence for an insertion–homolysis mechanism for carbon–sulphur bond formation in penicillin biosynthesis. Journal of the Chemical Society Chemical Communications. 856–858. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026